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A prophylactic or therapeutic vaccine offers the best
hope to curb the HIV-AIDS epidemic gripping sub-
Saharan Africa, but it remains elusive. A major chal-
lenge is the extreme viral sequence variability among
strains. Systematic means to guide immunogen
design for highly variable pathogens like HIV are
not available. Using computational models, we
have developed an approach to translate available
viral sequence data into quantitative landscapes of
viral fitness as a function of the amino acid
sequences of its constituent proteins. Predictions
emerging from our computationally defined land-
scapes for the proteins of HIV-1 clade B Gag were
positively tested against new in vitro fitness
measurements and were consistent with previously
defined in vitro measurements and clinical observa-
tions. These landscapes chart the peaks and valleys
of viral fitness as protein sequences change and
inform the design of immunogens and therapies
that can target regions of the virus most vulnerable
to selection pressure.
INTRODUCTION
A cheap, easily administered prophylactic or therapeutic vaccine
represents the best hope for arresting the global HIV-AIDS
epidemic (Baker et al., 2009), but it remains elusive after three
decades of effort. The recent discovery of antibodies that can
neutralize diverse HIV strains (Walker et al., 2011) and evidence
that a cytotoxic T lymphocyte (CTL)-based vaccine has the
potential to abort infection (Hansen et al., 2009, 2011) offer
hope, but important challenges remain. Prominent among these
is the ability of the virus to mutate to new variants that do not606 Immunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc.carry a significant penalty in replicative fitness (Autran et al.,
2008; Goulder and Watkins, 2004). The replicative fitness of
the virus is correlated with disease pathogenesis: infection with
low fitness viruses or the emergence of immune pressure-medi-
ated low fitness viruses is associated with improved control of
the viral load (Miura et al., 2010). It has been suggested, there-
fore, that vaccine-induced immune responses should be
focused on vulnerable regions of the virus, within which muta-
tions impose a high fitness cost (Goulder and Watkins, 2004;
Streeck et al., 2007; Walker et al., 2011).
Highly conserved residues have long been suggested as
a target for effective CTL responses (Le´tourneau et al., 2007;
Rolland et al., 2007; Streeck et al., 2007), but studies have shown
that viral fitness is also strongly influenced by couplings between
multiple simultaneous mutations (Allen et al., 2005; Brockman
et al., 2007, 2010; Brumme et al., 2009; Dahirel et al., 2011;
Draenert et al., 2004; Ferrari et al., 2011; Leslie et al., 2004;
Le´tourneau et al., 2007; Martinez-Picado et al., 2006; Miura
et al., 2009a; Miura et al., 2009a, 2009b; Schneidewind et al.,
2007, 2008; Troyer et al., 2009; Walker et al., 2011). These
couplings may arise, for example, due to the structural proximity
of groups of residues within the three dimensional protein struc-
ture or participation of the group in a particular viral function
involving multiple proteins. The coupling betweenmultiple muta-
tions may be compensatory—wherein the fitness of the viral
strain containing multiple mutations is higher than would be ex-
pected from the mutations occurring independently—or delete-
rious—wherein the multiple mutant is less fit than would be pre-
dicted from the single point mutations. Rare individuals capable
of controlling HIV infection without therapy (elite controllers)
naturally target multiple residues in groups of residues within
which multiple simultaneous mutations are particularly detri-
mental to viral fitness (Dahirel et al., 2011). Together, these
studies suggest that groups of residues containing deleterious
mutational couplings are promising new targets for vaccine-
induced immune attack (Dahirel et al., 2011).
A comprehensive knowledge of the fitness of viral strains con-
tainingmultiplemutations would reveal manymore regions of the
Figure 1. Cartoon Schematic of a Viral Fitness Landscape
The replicative fitness of a viral strain is a function of its amino acid sequence.
This information can be visualized as a topographical map where the amino
acid sequence specifies a location on the landscape, and the height of the
landscape prescribes viral fitness. For visualization purposes, this cartoon
pertains to a virus consisting of only two residues. For multiresidue viral
proteins, the fitness landscape is traced out in higher dimensions. The broken
line indicates a hypothetical high-fitness mutational escape pathway from the
global fitness maximum, to a nearby local maximum.
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immune targeting. This would open the possibility of designing
immunogens containing these vulnerable regions, which could
be presented by people with diverse HLAs to induce effective
CTL responses (similar to elite controllers). The ability to deter-
mine the fitness of any viral strain could also inform the design
of therapies based on antibodies and small-molecule inhibitors.
Systematic identification of regions where multiple mutations
are deleterious requires an approach that assigns a quantitative
measure of the replicative fitness to any viral strain containing
multiple mutations. First postulated by Sewall Wright in 1932
(Wright, 1932), the fitness landscape describes the replicative
capacity of the virus as a function of its amino acid sequence.
Effective antibody responses would target epitopes in viral
surface proteins defined by narrow peaks, because they are
likely to be conserved across strains. CTL responses should
target combinations of epitopes or protein residues where muta-
tions drive the virus from the high-fitness peaks into the valleys
where its compromised fitness impairs its ability to replicate
and inflict damage to the host. Furthermore, a potent vaccine
would also elicit additional responses to block viral escape to
nearby high-fitness strains identified by the fitness landscape.
Thus, viral fitness landscapes offer an unprecedented means
to identify vulnerable regions of the virus, and guide the design
of efficacious vaccine immunogens and therapies for diverse
viruses. Here, we present a method to determine the fitness
landscape of viruses and apply it to HIV.
The Shannon entropy (a measure of sequence variability) of
single residues and targeted epitopes is correlated with the
emergence of escape mutations and has been proposed as
a measure of the fitness cost of escape (Allen et al., 2005; Ferrari
et al., 2011). This measure, however, is restricted to localized
groups of residues and therefore largely ignores mutational
couplings that are known to be important determinants of viral
replicative fitness. Dahirel et al. recently presented a means to
qualitatively identify groups of sites possessing strong muta-
tional couplings (Dahirel et al., 2011), but this approach does
not furnish quantitative measures of viral fitness required to
construct the fitness landscape. Regression models have been
fitted to in vitro HIV fitness measurements as a function of amino
acid sequence (Hinkley et al., 2011; Kouyos et al., 2012).
However, such approaches require extensive and laborious
in vitro fitness measurements.
In contrast to these approaches, we have devised amethod to
obtain fitness landscapes by direct analysis of available protein
sequence databases, without appealing to experimental fitness
measurements.We apply ourmethodology to proteins within the
key HIV-1 structural polyprotein, Gag, and validate the inferred
fitness landscape by direct comparison to new and existing
experimental data and clinical observations. To illustrate one
utility of the inferred fitness landscapes, we use the landscapes
to design a Gag immunogen that is predicted to prime effica-
cious CTL responses in persons with diverse HLA haplotypes.
RESULTS
Model Development
Only a limited number of full-genome HIV sequences are
currently available. Analyses of these few sequences do notprovide sufficient statistical power for the development of
a unified fitness landscape for the entire HIV proteome, necessi-
tating that we pursue models for individual proteins. However,
our approach is directly extensible to the translation of full
genome sequence data to fitness landscapes as more
sequences become available. Conceptually, it is useful to visu-
alize the fitness landscape as a topographical map (Figure 1),
where the amino acid sequence of the virus determines the loca-
tion of the viral strain on themap, and the height of the landscape
prescribes its replicative fitness.
The HIV-1 structural polyprotein Gag is a promising target for
CTL responses, containing multiple peptides that are presented
by HLA class I molecules, and regions that are mutationally
restricted by structural and functional restraints (Dahirel et al.,
2011; Goulder and Watkins, 2004; Schneidewind et al., 2007,
2008; Troyer et al., 2009). A number of Gag residues exhibit dele-
terious mutational couplings (Dahirel et al., 2011). Thus, to
develop and illustrate the accuracy of our approach, we have in-
ferred fitness landscapes for the four principal Gag proteins: p6,
p7 (nucleocapsid), p17 (matrix), and p24 (capsid).
Multiple sequence alignments (MSA) for the four Gag proteins
in HIV-1 clade B were downloaded and processed from the Los
Alamos National Laboratory HIV database (http://www.hiv.lanl.
gov) as described in the Supplemental Experimental Procedures
available online. These data are compilations of consensus
sequences drawn from infected patients. Our goal is to infer
the viral fitness landscape from these data.
We described each sequence in the MSA by using a binary
code. If the amino acid at a particular residue in a protein
sequence is the wild-type (WT) amino acid, it is denoted by 0;
if the residue is any one of the 19 ‘‘mutant’’ amino acids, it is de-
noted by 1. Neglecting the particular identity of themutant amino
acid greatly reduces the computational cost of extracting fitness
landscapes, and is a good approximation for the relatively well-
conserved Gag polyprotein (cf. Supplemental Experimental
Procedures). The disadvantage is loss of residue-specificImmunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc. 607
Figure 2. Comparison of Our Theoretical Metric of Fitness (E) and
Experimental In Vitro Replicative Fitness Data
(A) In vitro replicative fitness was measured for 19 Gag single and double
mutants (cf. Experimental Procedures). A Pearson correlation coefficient of
r = 0.52 (p = 0.02) reveals a statistically significant negative correlation
between the energy difference of the engineered mutants relative to the WT
strain computed from our model, (E - Ewt) and the logarithm of the measured
relative fitness of the mutant, log(f/fwt).
(B) Replicative fitness data was compiled for 25 engineered Gag mutants
containing up to five point mutations (Brockman et al., 2007 [Jurkat cell], Miura
et al., 2009b, Troyer et al., 2009, Schneidewind et al., 2007, 2008). This data
also exhibits a strong negative correlation r = 0.81 (p = 2 3 107). In each
panel, a linear least-squares fit is provided to guide the eye, and error bars
delineating estimated uncertainties in the relative fitness are provided where
available.
Immunity
Translating HIV Sequences into Fitness Landscapesresolution, so that the fitness landscapes cannot differentiate
between mutant viral strains containing different amino acids in
the mutated positions.
The sequence data contain information on the probability of
occurrence of each single, double, triple, and higher order muta-
tion. A mathematical model reproducing these probability distri-
butions describes the evolutionary space accessible to HIV.
Because each protein comprises tens to hundreds of residues,
the number of possible double, triple, quadruple, etc., mutations
is extraordinarily large, making it intractable to fit a model
describing the probability distributions of mutations of all orders.
Instead, we follow themaximum entropy principle (Jaynes, 1957)
to seek the least biased model capable of reproducing the
observed probabilities of occurrence of every single and double
mutation (Mora and Bialek, 2011; Tkacik et al., 2006, 2009) and
use it to predict higher-order mutations. As described in the
Experimental Procedures, this leads us to infer a model where
the probability of occurrence of a particular sequence is
described by a well-studied model in physics, known as the in-
finite-range Ising spin glass (Binder and Young, 1986).
We found that mathematical models inferred in this way not
only reproduce the pattern of single and double mutations, but
also predict with high accuracy the observed probabilities of
occurrence of triple and quadruple mutants, and the probability
of observing a sequence containing any particular number of
mutations (cf. Supplemental Experimental Procedures). In fact,
depending upon the Gag protein, our mathematical models
capture 70%–99% of the information content on correlated
mutational interactions contained in the available sequences
derived from patients. Thus, our models have achieved the
goal of capturing the mutational patterns exhibited by the virus
within the MSA.
Having fittedmodels for each protein, a quantity, E, can be as-
signed to viral strains containing any combination of mutations
(cf. Experimental Procedures). In analogy with the physics litera-
ture, we refer to E as the ‘‘energy.’’ The value of E corresponding
to a particular mutant strain is related to the probability of
observing this strain within the population of all possible
mutants, whereby low-energy strains are highly prevalent and
high-energy strains comparatively rare. We assume that highly
prevalent—and therefore low energy—sequences in the popula-
tion correspond to strains with high intrinsic replicative fitness.
Our model suggests that log(f), where f is the fitness of any
mutant strain, should be negatively correlated with its energy
(cf. Equation 1). Under relatively restrictive assumptions, Sella
and Hirsh have precisely derived the connection between
E and fitness (Sella and Hirsh, 2005). However, the complex
interactions between HIV and the immune systems of diverse
individuals make it difficult to mathematically demonstrate that
our model obtains intrinsic viral fitness landscapes. Accordingly,
in the following sections we present strong evidence that E is
indeed a good proxy for fitness by testing our model predictions
against new and existing in vitro experimental data and clinical
observations from HIV-infected persons.
The Inferred Fitness Landscape Compares Well with
In Vitro Replicative Fitness Data
If our model for the fitness landscape inferred from sequence
data is a measure of intrinsic replicative viral fitness, we should608 Immunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc.observe a negative correlation betweenmeasured in vitro fitness
of mutant viral strains and our proposed metric of fitness, the
energy, E, corresponding to that strain. This is because our
model predicts that low E corresponds to high fitness (see
above). To test this hypothesis, we predicted the energy of 19
viral strains with single and double mutations in the p24 protein.
These mutations were introduced to the HIV-1 clade B NL4-3
backbone, and the in vitro replicative capacity of each strain
was measured (cf. Experimental Procedures). Each residue
was mutated to the most common mutant amino acid at that
position observed in the sequence data.
Following the prescription of our model (cf. Equation 1), we
plot the energy of strain i relative to the WT, (Ei  Ewt), against
the logarithm of its measured relative fitness, log(fi/fwt). We
observe a statistically significant negative correlation (Figure 2A,
Pearson correlation coefficient, r = 0.52 (p = 0.02, two-tailed
Fisher test)). The direct relationship between Ei and fi also
exhibits a strong negative correlation (Figure S1A, r = 0.68
Figure 3. Clinically Documented Mutant Strains Correspond to Low
Energy/High Fitness States within our Inferred Model
Clinically documented mutant strains correspond to low energy (high fitness)
states within our inferred model. Circles represent energies assigned by our
model to the 10 p24 single mutants, 8 p24 double mutants, and 5 p17 double
mutants listed within Table S1, which identifies the particular mutants, HLA
associated epitopes, and computed energies. Squares represent energies of
the strains of three p17 epitopes observed to undergo sequence adaptation in
longitudinal deep sequencing of an HIV-infected host (Henn et al., 2012). In all
cases, residues outside the epitope are treated as WT in the assignment of
energies.
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in vitro in the absence of immune pressure, these results suggest
that our inferred landscapes describe the intrinsic replicative
fitness effects of mutations in Gag.
To further test our model, we compiled 50 previously pub-
lished experimental measurements of the in vitro replicative
fitness of engineered p24 Gag mutants containing up to five
polymorphisms (Brockman et al., 2007; Crawford et al., 2007;
Miura et al., 2009a; Schneidewind et al., 2007, 2008; Troyer
et al., 2009). Because in inferring ourmodel we do not distinguish
between any of the 19 possible mutant amino acids at each posi-
tion observed in the MSA, our model is statistically most accu-
rate in describing the fitness effects of mutant strains containing
the most probable mutant amino acids at mutated positions.
Accordingly, we first compared our model to those 25 fitness
measurements in which the engineered polymorphism corre-
sponds to the single most probable mutant amino acid at that
position observed in the MSA. As for comparisons with our
own experimental data, we observed a strong negative correla-
tion between our predictions of the energy of a strain and its
measured in vitro replicative fitness (Figure 2B, r = 0.81
[p = 2 3 107]). The relationship between Ei and fi also
exhibits a strong negative correlation (Figure S1B, r = 0.75
[p = 63 106]). Despite the inaccuracy of the binary approxima-
tion for the other 25 published data points, the negative correla-
tion was maintained upon considering all 50 data points (Figures
S1C and S1D). In the Supplemental Experimental Procedures,
we describe an extension of our model that does not require
making the binary approximation.
The viral sequences used to parametrize our model were ex-
tracted from infected individuals, each of whom possessa unique adaptive immune response targeting different regions
of the HIV proteome. Thus, the effectively fittest viral strains in
each individual are expected to differ. Why, therefore, do we
see good correspondence between E and in vitro intrinsic repli-
cative fitness? Assuming the representation of HLA alleles to
approximately follow that of United States Caucasians
(Gonzalez-Galarza et al., 2011), the recognition frequencies of
the most common HLA restricted p17 and p24 epitopes
(Streeck et al., 2009) indicate that, of the 363 residues in p17
and p24, only 46 are targeted by more than 10% of the popula-
tion, no single residue is targeted bymore than 23%, and 146 are
not targeted at all. If we may assume that a diverse range of HLA
class I haplotypes are represented within the population from
which the sequences were obtained and that infecting strains
rapidly revert to replicatively more fit strains if the immune pres-
sure in a new host does not attack the region in which a mutation
was forced in the infecting host (Davenport et al., 2008; Friedrich
et al., 2004; Henn et al., 2012), then our models represent aver-
ages over haplotypes in the population. This averaging may
explain why our models appear to reflect the underlying intrinsic
viral fitness, rather than ‘‘footprints’’ of adaptive immune pres-
sure (Matthews et al., 2009).
Clinically Documented Escape Strains Correspond to
High Fitness Strains
Viral strains can escape CTL recognition by establishing one or
more point mutations within, or flanking, the target epitope. It
is expected that the clinically observed escape strains will be
those that permit the virus to evade immune recognition with
minimal cost to its replicative fitness, and should correspond
to low-energy strains in our model.
Published accounts of escape strains sequenced from HIV in-
fected individuals and statistical analyses of proximate HLA
associated polymorphisms allowed us to compile a list of p17
and p24 escape mutations against which to test our inferred
fitness landscape (Brockman et al., 2007, 2010; Brumme et al.,
2009; Draenert et al., 2004; Leslie et al., 2004; Martinez-Picado
et al., 2006; Miura et al., 2009b; Schneidewind et al., 2007,
2008; Troyer et al., 2009). In p24, we gathered a set of ten single
and eight double mutants, and in p17, a set of five double
mutants and one triple mutant. In contrast to Shannon
entropy-based approaches that consider the variability of single
residues or epitopes in isolation (Allen et al., 2005; Ferrari et al.,
2011), our method permits quantitative ranking of any multiresi-
due mutant according to the value of E (proxy for fitness) as-
signed by our model. The particular mutants, HLA associated
epitopes, and computed energies are listed in Table S1. The
energy assigned to each mutant by our model is shown in
Figure 3.
Of the p24 single mutants, nine out of ten possess energies
within the bottom 11.7% of the spectrum of 231 possible
single-mutant strains (E < 8.4). The remaining candidate,
carrying a mutation at position 264, possesses an energy
E = 19.4, placing it at the 29th percentile of the energy spec-
trum. The low fitness (high energy) apparently tolerated by
this mutant is explained by the observation that mutations of
this residue are never observed in isolation, but only in concert
with a mutation at position 268 (Schneidewind et al., 2007). We
find that the interaction coupling between these residues isImmunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc. 609
Figure 4. Escape Mutations Associated with HLA B*57 in the TW10
(Gag240–249) Epitope Occur at Residues Predicted to Incur the Small-
est Fitness Penalty
Comparison of point mutant energy costs with documented B*57 associated
escape mutations in the TW10 (Gag240–249) epitope in p24. The ten residues
constituting the epitope are indexed along the abscissa, and the energy cost
associated with making a point mutation at each position, DE, is along the
ordinate. The greater the energy cost, the higher the fitness penalty. Mutations
at position 246 were not observed within our sequence alignments, leading to
the specification within our model of an infinite energy cost of a point mutation
at this position, which we denote by *. The observed escape mutations at 242
and 248 (Brumme et al., 2009) occur precisely at the two positions carrying the
lowest energy cost (smallest fitness penalty).
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a low energy (E = 11.0) corresponding to the bottom 1.3% of
the spectrum. A third compensatory mutation is also frequently
observed at position 173 (Schneidewind et al., 2007), leading to
further compensation, and a highly fit triple mutant (E = 2.9).
This progression of compensatory interactions demonstrates
the ability of our model to capture couplings between multiple
simultaneous mutations throughout the protein, which cannot
be achieved by the Shannon entropy of single residues or
epitopes.
All eight of the p24 double mutants reside within the bottom
4.2% of the energy spectrum of all possible 26,565 doubly
mutated strains. Similarly, the energies of four of the five p17
double mutants lie in the bottom 6.1% of the 8,646 possible
double mutants. The remaining double mutant resides in the
31st percentile. While the p17 triple mutant possesses an
energy E = 16.99, flipping one particular residue back to WT
results in a highly fit (E = 1.03) double mutant that is the 13th
lowest energy strain of all 8,646 possible double mutants
(0.15% energy percentile) (cf. Table S1). We note that we iden-
tified the p17 triple mutant from a statistical analysis of poly-
morphisms in the vicinity of the A11-TI9 epitope at Gag84–92
(Brumme et al., 2009), rather than an observation of this strain
within an infected person.
By cross-referencing the list of best-defined HIV CTL epitopes
(the CTL ‘‘A list’’) (Frahm et al., 2008), with a compilation of statis-
tically significant HLA associated polymorphisms (Brumme
et al., 2009), we identified 25 epitopes in p17 and p24 with
defined CTL escape mutations. If we assume that all point muta-
tions within, or flanking, these epitopes lead to equally efficient
CTL escape, our inferred fitness landscape predicts that escape
mutations should correspond to those residues in epitopes that
incur the smallest energy penalty upon mutation and thus maxi-
mally preserve viral fitness.
As illustrated in Figure 4, the well-documented B*57 associ-
ated escape mutations at positions 242 and 248 in the TW10
(Gag240–249) epitope in p24 (Brumme et al., 2009) coincide
precisely with the point mutations leading to the lowest fitness
penalty (lowest energy cost). Similar results for the 24 remaining
examples are presented in Figure S2 In 21 of 25 cases, the
observed escape mutation—or one such mutation in epitopes
where multiple escapes are observed—occurs at precisely the
least costly, or next least costly, position. Of the four remaining
cases, two of the documented escape mutations identified by
statistical analyses are defined as ‘‘indirect’’ HLA associations
(Brumme et al., 2009), implying that they may exist as compen-
satory mutations elicited by a prior mutation in other proteins,
rather than as primary escapes to evade CTL pressure. Our
models have been constructed for single proteins and are there-
fore capable of capturing mutational couplings between resi-
dues within the same protein. As more whole-genome
sequences become available, our method can be applied to
identify the fitness effects of interprotein couplings.
The fact that the preponderance of escape mutations
observed in people with different genotypes are high fitness
(low energy) strains further supports the hypothesis that the in-
ferred fitness landscape reflects intrinsic viral fitness, and not
immune footprints of individuals with particular HLAs. Not all
high fitness mutant strains are clinically observed, due in part610 Immunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc.to finite sampling of the circulating strains, redundancy in the
genetic code rendering mutations of some amino acids intrinsi-
cally more difficult than others, and that not all positions are
subject to immune pressure-driven mutations.
Temporal Patterns of Mutations in Individual Patients
Follow High-Fitness Routes
As a further, stringent test of whether our models reflect intrinsic
viral fitness, we compared our predictions to recently reported
longitudinal deep sequencing within a single host over the first
4 years of HIV infection (Henn et al., 2012). Three of the six
sequenced CTL Gag epitopes in this individual exhibited
sequence adaptation over the course of infection. Comparison
of the observed sequence adaptations to the fitnesses (energies)
computed from our model show that they populate the high
fitness (low energy) states of the inferred landscape (Figure 3)
and, the temporal adaptation courses follow high fitness (low
energy) routes (Figure 5).
As illustrated in Figure 5A, the infecting strain contained two
mutations within the KW9 (Gag28–36) epitope, presumably driven
by immune pressure in the previous host (Henn et al., 2012). They
occur at the second and third energetically least costly positions
predicted by our model, and the energy of this double mutant is
in the bottom 3.3% of all double mutants. By day 1,543 of infec-
tion, 79.5% of the population had reverted to WT. The LY9
(Gag78–86) epitope of the infecting strain (Figure 5B) contained
a point mutation at the least costly position. By day 1,543,
31.3% of strains had reverted to WT, with the remaining strains
split between three other states that we predict to be highly fit.
The energies of these four states are very close, suggesting
that stochastic fluctuations may have populated the marginally
less fit states. Finally, the GY9 (Gag71–79) epitope in the infecting
strain (Figure 5C) carried a single mutation at the second least
Figure 5. The Inferred Fitness Landscape
Describes Viral Evolution in Individual
Patients
Longitudinal deep sequencing within a single in-
fected host identified three p17 CTL Gag epitopes
as undergoing sequence adaptation during the
first 4 years of HIV infection (Henn et al., 2012). In
(A)–(C), the title provides the location of each CTL
epitope within Gag (e.g., Gag28–36), the HLA
association (e.g., A24), and the name of the
epitope (e.g., KW9). On the left side, we present
bar charts illustrating our inferred h parameter (c.f.
Experimental Procedures) at each position in the
epitope. On the right, we list the strains observed
by deep sequencing at the six time points (Henn
et al., 2012), the fraction of the deep sequencing
reads corresponding to each strain (Henn et al.,
2012), and the energy of each strain assigned by
our model. Red letters indicate point mutations
relative to ourMSA consensus; all residues outside
the epitope are treated as WT in the computation
of energies from our model. In (D), we present the
temporal adaptation courses tracking the energy
assigned by our model to the mutant strains of
each epitope sequenced at each time point.
(A) The infecting strain contains two mutations in
the KW9 epitope (Gag28–36) at positions 28 and 34,
corresponding to the positions with the second
(h28 = 1.50) and third (h34 = 2.12) lowest h values
and a compensatory J coupling (J28,34 =0.15, c.f.
Experimental Procedures), lowering the energy of
the double mutant relative to the two independent
point mutations. By day 476, 61.5% of the viral
population has reverted to the lower energy single
mutant (h28 = 1.50). By day 1,543, 79.5% of viral
strains have reverted to the lowest energy (E = 0)
WT state. The remaining 20.5% occupy the third
least costly singly mutated state (h34 = 2.12). The
lowest (h30 = 0.55), second lowest (h28 = 1.50), and
third lowest (h34 = 2.12) singly mutated states are
similar in energy.
(B) The LY9 epitope (Gag78–86) enters with a single
mutation in the infecting strain at the single lowest
energy position (h82 = 0.17). No sequence adap-
tation is observed until day 1,543, at which time
31.3% of the population has reverted to the lowest
energy (E = 0) WT, 57.1% of the population occupy the second lowest energy singly mutated state (h79 = 0.97), 6.3% occupy a low energy doubly mutated state
(h79 = 0.97, h82 = 0.17, J79,82 = 0.25), and 5.4% remain in the infecting state.
(C) The GY9 epitope (Gag71–79) entered with a single mutation at the second least costly position in the epitope (h76 = 1.30), nearly equienergetic with the least
costly point mutation (h79 = 0.97). By day 165, the WT strain transiently emerged in 30.8% of the population but vanished by day 476. At day 1,543, 37.8% of the
population remains in the infecting state. The remaining 62.2% possess mutations at the second least costly (h79 = 0.97) and least costly (h76 = 1.30) positions,
and a small compensatory coupling (J76,79 =0.04). This double mutant is of very low energy, lying within the lowest 1%of all 8,646 possible p17 double mutants.
Of the three epitopes considered, only for GY9 is a significant fraction of the day 1,543 population not observed in the lowest energy WT state, although it
transiently emerges in day 165. Of the three epitopes, GY9 was the only one against which a CTL response was reported (Henn et al., 2012), consistent with
a situation in which the WT state is effectively less fit than a competing mutant strain capable of evading immune pressure.
(D) Temporal adaptation courses follow high fitness (low energy) routes for each of the three epitopes: KW9 (red circles), LY9 (green squares), and GY9 (blue
triangles).
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of strains, to be replaced in 62.2%of the population by day 1,543
with a highly fit double mutant residing within the bottom 1% of
all double mutants. In Figure 5D, we show the temporal adapta-
tion courses of the three epitopes. Of the three epitopes, a CTL
response was reported against only GY9 (Henn et al., 2012). This
response may render the WT strain effectively less fit than higher
energy mutants that are able to evade immune pressure.Accordingly, in the presence of this immune pressure, the WT
may be outcompeted by a highly fit double mutant, offering
a plausible rationalization for its observed transient emergence
and disappearance.
That the strains observed during sequence adaptation within
a single host correspond to the high fitness (low energy) muta-
tions predicted by our model, further substantiates our inferred
landscapes as reflections of intrinsic viral fitness.Immunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc. 611
Figure 6. Fitness Costs Associated with Targeting Different HLA-
Associated Immunodominant Epitopes
Rank-ordered bar chart of 121 p24 class I HLA epitopes according to the
computed energy penalty, D < E >, imposed upon the viral ensemble. The
particular epitopes considered are listed in Table S2. Epitopes associated with
a reported immunodominant response within a particular HLA class I allele
(Streeck et al., 2009) are designated by colored bars and labeled with the
epitope location and HLA association. Red bars indicate that the corre-
sponding HLA allele has been linked with enhanced HIV control, whereas blue
bars denote those that have not (Miura et al., 2009b; Pereyra et al., 2010;
Trachtenberg and Erlich, 2001). The immunodominance data pertaining to the
B*57 KF11 epitope Gag162–172 were assumed to also apply to the epitope
formed from its nine residue subset, Gag164–172. Six of the seven immunodo-
minant epitopes leading to the greatest fitness cost are associated with
protective HLA alleles; the dashed line at D < E > = 1.54 represents the cutoff
above which all immunodominant responses are associated with protective
alleles.
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Controllers Incur the Largest Fitness Costs
A diversity of HIV mutant viral strains exists within an infected
host (Lee et al., 2008). Viral populations containing strains with
lower replicative fitness have been correlated with better disease
control (Miura et al., 2010). We hypothesized that our model may
be able to identify effective CTL immune responses as those that
give rise to mutations that significantly decrease the average
fitness of the viral population within a host.
The results we have reported strongly suggest that the energy,
Ei, of a particular viral strain, i, is a good measure of its intrinsic
replicative fitness. To simulate the diversity of viral strains that
may exist within an infected host, we used the energies pre-
dicted by our model to generate a large ensemble of mutant
strains in which each is represented in proportion to its fitness
(cf. Equation 1; Supplemental Experimental Procedures). The
average fitness of an ensemble of sequences should correlate
with its average energy, < E > = Si P(i) Ei, where P(i) is the prev-
alence of strain i in the ensemble.
We suggest that an effective immune response will signifi-
cantly increase the average energy (decrease the average
fitness) of the ensemble of viral strains in an individual. Such
responses will preferentially eliminate high-fitness viral strains,
leaving behind unfit strains that are less able to replicate and
damage the host. Conceptually, this corresponds to deletion of
those strains residing near the peaks of the fitness landscape,
causing the ensemble as a whole to be pushed into the low-
fitness valleys (cf. Figure 1). The fitness cost upon targeting612 Immunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc.a particular CTL epitope was quantified as the change in < E >,
D < E >, upon removing from the ensemble all viral strains with
WT amino acids in the targeted epitope, simulating the effect
of CTL elimination of these strains. Our model predicts that tar-
geting epitopes associated with larger values of D < E > should
result in better control of HIV infection.
Using this criterion, we rank-ordered the 121 p24 epitopes
defined in the Los Alamos HIV Molecular Immunology Data-
base (http://www.hiv.lanl.gov/content/immunology) listed in
Table S2. We define a particular HLA associated epitope to
be immunodominant if its cognate CTL response is observed
in more than 50% of patients expressing this HLA in either
the chronic or acute phase of infection (Streeck et al., 2009).
Available immunodominance data allowed us to identify 12
such epitopes, of which 8 are associated with protective HLA
alleles that clinical and genome wide association studies have
linked with superior ability to control HIV infection (Hendel
et al., 1999; Pereyra et al., 2010; Streeck et al., 2009; Trachten-
berg and Erlich, 2001) (Table S2). As illustrated in Figure 6, the
three immunodominant epitopes that lead to the greatest
fitness costs, and six of the seven immunodominant epitopes
leading to the greatest fitness costs, are presented by HLA
molecules associated with persons who can naturally control
HIV infections (Hendel et al., 1999; Miura et al., 2009b; Pereyra
et al., 2010; Trachtenberg and Erlich, 2001). We find, therefore,
that elite controllers target epitopes where mutational escape
incurs the largest fitness costs, consistent with the observation
that viral strains extracted from these persons have impaired
replicative capacity (Miura et al., 2009b). Notably, the results
in Figure 6 pertain to multiple HLA types, providing further
support for the assertion that our landscapes describe intrinsic
viral fitness, rather than ‘‘footprints’’ of adaptive immunity
(Matthews et al., 2009). Our results also suggest that we can
predict disease pathogenesis from knowledge of viral strains
in a patient because we can determine the average fitness of
the in-host viral population. As an aside, we observe that the
negative D < E > value corresponding to epitope 121 reflects
an immune pressure that preferentially removes unfit strains, al-
lowing the remaining fitter strains to occupy a larger fraction of
the population. This effect may suggest a possible interpreta-
tion for failed vaccine trials that led to increased viral loads
and a reduction in time to antiretroviral treatment resumption
(Autran et al., 2008).
Dahirel et al. identified groups of residues (‘‘sectors’’) in Gag
subject to mutational couplings particularly detrimental to viral
fitness (Dahirel et al., 2011). The three top-ranked immunodomi-
nant epitopes in our model contain five, six, and seven residues,
respectively, within the top sector of Dahirel et al. containing the
most detrimental couplings, whereas the nine remaining
epitopes each contain four residues or fewer. This suggests
that our landscapes are capable of identifying vulnerable protein
regions containing deleterious mutational couplings.
Not all immunodominant p24 epitopes associatedwith protec-
tive alleles will lead to large fitness costs, because each allele
may mediate its beneficial effect through only a small fraction
of the epitopes it targets. For example, B*27 is a protective allele,
with chronic phase escape from its KK10 (Gag263–272) epitope
associated with progression to AIDS (Pereyra et al., 2010;
Schneidewind et al., 2007; Trachtenberg and Erlich, 2001). The
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least) two factors. First, this epitope contains only three residues
from Dahirel et al.’s top sector (Dahirel et al., 2011). Nine B*27
epitopes are defined within our list of 121 epitopes, containing
a total of 11 residues within this sector. Targeting the KK10
epitope in isolation may lead to only a modest reduction in viral
fitness, whereas targetingmultiple B*27 epitopes simultaneously
may lead to a more substantial fitness loss due to additional
deleterious couplings. Second, the protective action of B*27
may lie elsewhere in the proteome, as suggested by recent
work demonstrating a strong B*27 response to the KY9 Pol
epitope (Friedrich et al., 2011; Payne et al., 2010).
The available data allowed us to identify only one immunodo-
minant CTL epitope within p17, and none within p6 and p7,
thereby precluding similar analyses for these proteins (Streeck
et al., 2009).
The Inferred Fitness Landscapes Can Be Used for In
Silico Immunogen Design
As one illustration of the value of fitness landscapes, we consider
the design of CTL Gag immunogens that may induce potent
immune responses in people with diverse genotypes. We
observe that this strategy may be directly extended to guide
the design of antibody immunogens, combinations of potent
antibodies, or small molecule inhibitors.
Peptides from regions of HIV that are particularly vulnerable to
multiple mutations tend to be immunodominantly targeted by
CTLs in persons possessing protective HLA molecules (Dahirel
et al., 2011). In contrast, nonprotective HLA molecules domi-
nantly present epitopes from regions where mutational escape
from immune pressure is relatively easy. Nonprotective HLAs
can target peptides from vulnerable regions only subdominantly
when the whole proteome is presented (cf. Table S2) (Dahirel
et al., 2011; Streeck et al., 2009). The previous section demon-
strates that our landscapes can identify vulnerable regions of
the viral proteome that can be presented subdominantly (or
dominantly) by diverse HLAs. An immunogen designed to prime
these responses, whereas excluding dominantly presented
regions from which mutational escape is easy, could, if properly
delivered as a vaccine, elicit effective immune responses within
hosts with diverse haplotypes.
We consider the design of a CTL Gag immunogen for a target
population comprising the top 21 haplotypes of North Americans
with European ancestry, accounting for 44.6% of this popu-
lation (http://www.ncbi.nlm.nih.gov/projects/gv/mhc). Cross-
referencingwith the list of optimally defined ‘‘A list’’ CTL epitopes
(Frahm et al., 2008), we found that the class I HLA-A, HLA-B and
HLA-C molecules in this population restrict p = 1, 0, 10, and 20
epitopes in p6, p7, p17, and p24, respectively. For each Gag
protein, we constructed all possible combinations of 1,2,3,.,p
epitopes, where each combination represents an immunogen
candidate. There are 1, 1,023, and 1,048,575 combinations for
p6, p17, and p24, respectively. The efficacy of each candidate
in each of the 21 haplotypes was evaluated by identifying those
epitopes in the immunogen that could be presented by HLA
molecules constituting the haplotype and the fitness penalties
upon simultaneously targeting these epitopes. The penalty, D <
E >, was calculated in the manner described in the previous
section. The fitness penalty exacted by forcing mutations withinthe epitopes comprising each immunogen candidate, i, in each
haplotype, j, is denoted as DhEiji.
We evaluated each immunogen candidate, i, derived from
each of the three proteins according to three criteria: (1) the
weighted average fitness impact in the target population,
DhEii =
P21
j=1ujDhEiji, where uj is the fraction of haplotype j in
the target population, (2) the fraction of the target population
that respond to at least one epitope in the immunogen (fractional
coverage), and (3) the number of epitopes in the immunogen. The
performance of all p6, p17, and p24 immunogen candidates
according to these three criteria are presented in Figures 7A–
7C. Within this candidate pool for each protein, we identified
candidates such that immunogens that are superior to them in
any one criterion (increased fitness penalty, higher population
coverage, fewer included epitopes) are inferior in one or more
of the other criteria. These immunogens constitute the ‘‘optimal
frontier’’ (or ‘‘Pareto frontier’’; Arora, 2011) of the candidate pool,
where improvements in any one criterion are necessarily accom-
panied by a deterioration in another. Candidates that do not lie
on the frontier are suboptimal, because improvements may be
made in any one criteria without incurring a penalty in another.
For p6, p17, and p24, we identified 1, 25, and 44 optimal candi-
dates for inclusion in an immunogen. Their epitope compositions
are listed in Tables S3–S5. The evaluation criteria may be altered
without changing the approach. For example, in Figures 7D–7F
we show the results of calculations in which criterion (ii) was
modified to evaluate the fraction of the target population that
respond to at least two epitopes.
There are (1 + 1)3 (25 + 1)3 (44 + 1) = 2,340 candidate immu-
nogens for the combined [p6, p17, p24] polyprotein formed from
the combination of candidates on the optimal frontier for each
individual protein, plus the ‘‘null’’ immunogen containing no
epitopes in a particular protein. By using the same criteria as
before, we identified 95 Gag polyprotein immunogens on the
optimal frontier Figure 7G. Their composition is listed in Table
S6. As this table shows, our strategy permitted the identification
of a 12 component (113 residue) immunogen with 100%
coverage of the target population (i.e., all members respond to
at least one epitope). Similar optimizations could be carried out
to define potent immunogens where each member of the popu-
lation responds to two, or three, or more epitopes. In future work,
we plan to test the efficacy of our designed Gag immunogens in
inducing potent CTL responses in vitro and in animal models.
DISCUSSION
HIV is a highly mutable virus that also replicates very rapidly. The
large diversity of viable viral strainsmakes it difficult for the adap-
tive immune system to mount natural responses that effectively
control the virus (Autran et al., 2008; Goulder and Watkins,
2004). Immune responses or therapeutic agents that target
regions of the viral proteome where mutations lead to a large
cost in replicative fitness can be very effective for viral control
or aborting the infection (Dahirel et al., 2011; Goulder and
Watkins, 2004; Streeck et al., 2007). Systematic means to derive
the viral fitness landscape permits the identification of such
regions. These landscapes, therefore, offer an unprecedented
guide for the rational design of vaccine immunogens that could
redirect the adaptive immune response toward regions of theImmunity 38, 606–617, March 21, 2013 ª2013 Elsevier Inc. 613
Figure 7. Evaluation of Immunogen Candidates
(A–C) Scatter plots of (A) p6, (B) p17, and (C) p24 vaccine candidates in the three-dimensional design space spanned by: (1) the weighted average fitness impact
in the target population, DhEi, (2) fraction of the target population that respond to at least one epitope in the immunogen (fractional coverage), and (3) the number
of components in the vaccine. The target population comprised the 21 most prevalent haplotypes in North Americans of European ancestry, accounting for
(legend continued on next page)
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Translating HIV Sequences into Fitness Landscapesvirus most vulnerable to attack. They could also help design
optimal combinations of passively-administered antibodies
and small molecule therapeutic inhibitors that could neutralize
diverse strains.
We report a computational method that can translate viral
sequence databases into quantitative landscapes of intrinsic
fitness of viral strains containing multiple, potentially synergistic,
mutations. We have applied this approach to proteins contained
in Gag and positively tested our predictions against experiments
and clinical data.
As one illustration of how to leverage the insights furnished
by inferred fitness landscapes, we have designed a Gag
immunogen to prime CTL immune responses against vulner-
able regions of the viral proteome within a target human
population. Recent experiments with mousepox virus suggest
that such long-peptide immunogens, if properly delivered, can
redirect the host immune system to mount CTL responses
capable of conferring protective immunity upon mice that
are otherwise naturally susceptible to infection (Remakus
et al., 2012). Similarly, Melief, van der Burg, and coworkers
have reported the efficacy of long-peptide immunogens to
kill cancerous tumors if they are delivered in a way that results
in highly immunogenic responses (Melief and van der Burg,
2008). We plan to test our immunogen in animal models
with optimized delivery approaches that result in sufficient
immunogenicity.
Subject to continued validation, the approach we have devel-
oped provides a general methodology to translate viral sequence
data into fitness landscapes. With both viral sequencing and
computational hardware costs rapidly declining, our method-
ology offers ameans to compute full-genome fitness landscapes
for diverse viral pathogens— and possibly cancers—as suffi-
ciently large numbers of sequences become available. This
methodology may therefore represent a potentially powerful
tool to guide the design of improved prophylactic and thera-
peutic strategies.EXPERIMENTAL PROCEDURES
Fitness Landscape Inference
Under the binary approximation, the sequence of an m-residue protein may be
specified by the m-dimensional vector z!, the elements of which, fzigmi= 1, indi-
cate whether the amino acid at position i is WT, zi = 0, or mutant, zi = 1. The
maximum entropy model that fits the one- and two-body mutational probabil-
ities is the Ising spin glass model (Binder and Young, 1986). The probability of
observing a particular sequence, z!, within the population of all possible
mutants is
Pð z!Þ= 1
Z
eEð z
!Þ; Eð z!Þ=
Xm
i= 1
hizi +
Xm
i= 1
Xm
j= i+ 1
Jijzizj: (Equation 1)
In analogy with spin glasses, we refer to E as a dimensionless ‘‘energy,’’ and
the normalizing factor Z=
P
fzig= f0;1ge
Eð z!Þ as the partition function. The hi44.6% of this population. Respectively, 1, 1,023, and 1,048,575 immunogen cand
candidates were located on the Pareto frontier (red circles). The composition of
(D–F) Scatterplots analogous to those in (A)–(C) for (D) p6, (E) p17, and (F) p24,
respond to at least two epitopes in the immunogen; 1, 31, and 62 candidates ar
(G) Scatter plot of the 2,340 combination Gag vaccine candidates in the three-dim
the target population, DhEi, (2) fraction of the target population that respond to at
components in the vaccine. The compositions of the 95 Pareto efficient candidaand Jij model parameters are inferred from the one- and two-point mutational
probabilities observed in the protein sequence data using a semianalytical
extension of the iterative gradient descent implemented by Mora and Bialek
(2011). We detail this procedure in the Supplemental Experimental Proce-
dures, along with a description of the Monte-Carlo procedure used to sample
from the fitted models for each of the four Gag proteins.
Replicative Fitness Assays
The following mutations and mutation combinations were introduced into
a HIV-1 subtype B NL4-3 plasmid using the QuikChange II XL Site-Directed
Mutagenesis kit (Stratagene, La Jolla, CA), as previously described (Wright
et al., 2012): 146P, 147L, 146P/147L, 219Q, 242N, 219Q/242N, 186I, 310T,
295E, 182S, 179G, 229K, 331R, 190I, 302R, 315G, 168I, 326S, 310T/326S.
To generate the mutant viruses, we electroporated 10 mg of mutant plasmids
into an HIV-1-inducible GFP-reporter T cell line by using conditions described
previously (Huang et al., 2011), and virus growth was subsequently monitored
by detection of GFP-positive cells by flow cytometry (Brockman et al., 2010;
Wright et al., 2012). Replication capacities of mutant viruses were similarly as-
sayed in the GFP-reporter T cells by flow cytometry (Brockman et al., 2010;
Wright et al., 2012). Briefly, cells were infected at a MOI of 0.003 and the expo-
nential slope of increase in the percentage infected cells between days 3 and 6
postinfection was calculated as the measure of viral replication capacity.
Replication capacities of mutant viruses were expressed relative to that of
theWTNL4-3 virus, included as a control in every assay, such that a replication
capacity of 1 indicated replication equal to that of NL4-3. Assays were per-
formed in triplicate and the results averaged.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, six tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2012.11.022.
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